Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01617906

Ligand	Ligand name	Chain	PDB	Tanimoto
ECA	N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3-DIHYDROXYBENZAMIDE)	A,B	2CHU	0.74
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.7
CR7	[(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID	A	2A47	0.7
CR7	[(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID	A	2A48	0.7
CR7	[(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID	A	2A46	0.7
0E4	N-acetyl-L-tyrosyl-L-valyl-L-alanyl-L-aspartic acid	B,D	3GJS	0.72
DHC	CAFFEIC ACID	A,B,C,D,E,F,G,H	2O7D	0.7
DHC	CAFFEIC ACID	A	1KOU	0.7
ALE	L-EPINEPHRINE	A	3PAH	0.73
ALE	L-EPINEPHRINE	A	2HKK	0.73
TMS	N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY-PHENYL)-VINYL]-BENZAMIDE	A,B	1X6W	0.71
AEG	4-[(2R)-2-aminopropyl]phenol	A	3BUF	0.71
EB4	N,N',N''-[(3S,7S,11S)-2,6,10-trioxo-1,5,9-trioxacyclododecane-3,7,11-triyl]tris(2,3-dihydroxybenzamide)	A,B,C	3CMP	0.73
VRV	6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE	A	2OBJ	0.7
LDP	L-DOPAMINE	A,B	2A3R	0.75
LDP	L-DOPAMINE	A	5PAH	0.75
LDP	L-DOPAMINE	A,B	2QMZ	0.75
LDP	L-DOPAMINE	A,B	2VQ5	0.75
ZYA	BENZOYL-TYROSINE-ALANINE-METHYL KETONE	A	1AIM	0.73
TYP	CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR	A,B	1W1Y	0.73
3XH	3-Hydroxyhippuric acid	A	3E9K	0.72
DAH	3,4-DIHYDROXYPHENYLALANINE	A,B	1RNR	0.72
DAH	3,4-DIHYDROXYPHENYLALANINE	A	6PAH	0.72
DAH	3,4-DIHYDROXYPHENYLALANINE	A,B	1IVV	0.72
Y13	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	A	2EW6	0.89
CMQ	N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE	A,B,C,D,E,F,G,H,I,J,K,L,M,N	2FZS	0.73
TY3	3-HYDROXY-L-TYROSINE	A,B	2VH3	0.72
C1N	N-[(BENZYLOXY)CARBONYL]LEUCYL-N~1~-[3-FLUORO-1-(4-HYDROXYBENZYL)-2-OXOPROPYL]LEUCINAMIDE	A	1ZCM	0.73
TYC	L-TYROSINAMIDE	A	2BF9	0.73
TYC	L-TYROSINAMIDE	A	2OCI	0.73
YTT	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	A	3G5H	0.77
IYG	N-ALPHA-ACETYL-3,5-DIIODOTYROSYLGLYCINE	A	1OPM	0.71
TI2	(2-SULFANYL-3-PHENYLPROPANOYL)-PHE-TYR	A	1QF0	0.71
GAH	N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}-3-CYCLOHEXYL-L-ALANYL)AZETIDIN-2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]-L-LYSINAMIDE	A,H	1XM1	0.7
099	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	A,B	3HYG	0.71
LNR	L-NOREPINEPHRINE	A,B	2QEO	0.7
LNR	L-NOREPINEPHRINE	A	3DYE	0.7
LNR	L-NOREPINEPHRINE	A	4PAH	0.7
SD2	N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE	A,B	1PWQ	0.7
Y12	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	A	2EW5	0.75
DBS	2-(2,3-DIHYDROXY-BENZOYLAMINO)-3-HYDROXY-PROPIONIC ACID	A,B,C	1L6M	0.73
DBS	2-(2,3-DIHYDROXY-BENZOYLAMINO)-3-HYDROXY-PROPIONIC ACID	A,B,C	3CBC	0.73
DBS	2-(2,3-DIHYDROXY-BENZOYLAMINO)-3-HYDROXY-PROPIONIC ACID	A,B,C	3BY0	0.73
NLT	N-DODECANOYL-L-TYROSINE	A,B,C,D,E,F,G,H	2G0B	0.75